This site is intended for UK Healthcare Professionals only

UK/FLY/2023/2636 V4| October 2024

Prescribing information and adverse event reporting statement can be found in the footer

This site is intended for UK Healthcare Professionals only

UK/FLY/2023/2636 V4| October 2024

Prescribing information and adverse event reporting statement can be found in the footer

a

The ABC of Vitamin D

Now available on demand - This event outlines the role of vitamin D within the human body, along with the effects of vitamin D deficiency on health. It explores the evidence base for the pharmacological management of vitamin D deficiency and examines the clinical benefits of different treatment options for hypovitaminosis D.

Products

Flynn is a privately held pharmaceutical company with interests in secondary care and specialist medicine in both adult and paediatric patients.

Our portfolio of products

The company is engaged in a wide range of therapy areas including general medicine, NDD, psychiatry, paediatrics, post-operative pain management, anti-infective medicine, women's health, and emergency medicine. We supply both branded and generic medicines including a wide range of injectable and oral antibiotics.

Flynn focuses on providing medicines for many groups of patients, often by re-discovering and re-energising already established drugs and branded pharmaceutical products. We seek to continue to deliver patient benefits through introducing new products, improving existing formulations or adding new indications.

Domnisol®

Formulation: Soft capsules (calcifidiol monohydrate)

Indication:

  • Treatment of vitamin D deficiency in adults.
  • Prevention of vitamin D deficiency in adults with identified risks.
  • As an adjunct to specific therapy for osteoporosis in patients with vitamin D deficiency or at risk of vitamin D insufficiency.

REQUEST A MEETING

Send a virtual meeting request